Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction-Reference-Cited by-同舟云学术

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction

Published:2010-01-28 Issue:3 Volume:24 Page:F1-F9
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Martínez Esteban,Larrousse María,Podzamczer Daniel,Pérez Ignacio,Gutiérrez Félix,Loncá Montserrat,Barragán Patricia,Deulofeu Ramón,Casamitjana Roser,Mallolas Josep,Pich Judit,Gatell José M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference18 articles.

1. A:D Study Group. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multicohort collaboration.;Lancet,2008

2. Abacavir and increased risk of myocardial infarction;Post;Lancet,2008

3. Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine;Shlay;JAIDS,2005

4. Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study;Podzamczer;J Acquir Immune Defic Syndr,2007

5. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection;Martínez;N Engl J Med,2003

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Porcelain Aorta in a Young Person Living with HIV Who Presented with Angina;Diagnostics;2022-12-13

2. Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges;Microorganisms;2022-02-14

3. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association;Circulation;2019-07-09

4. Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studies;International Journal of Antimicrobial Agents;2018-11

5. Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women;HIV Medicine;2018-08-30